What is the share price of Max Healthcare Institute Limited (MAXHEALTH) today?
The share price of MAXHEALTH as on 9th October 2026 is ₹883.80. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Max Healthcare Institute Limited (MAXHEALTH) share?
The past returns of Max Healthcare Institute Limited (MAXHEALTH) share are- Past 1 week: -4.76%
- Past 1 month: -10.97%
- Past 3 months: -19.75%
- Past 6 months: -7.45%
- Past 1 year: -23.53%
- Past 3 years: 55.43%
- Past 5 years: 153.71%
What are the peers or stocks similar to Max Healthcare Institute Limited (MAXHEALTH)?
The peers or stocks similar to Max Healthcare Institute Limited (MAXHEALTH) include:What is the dividend yield % of Max Healthcare Institute Limited (MAXHEALTH) share?
The current dividend yield of Max Healthcare Institute Limited (MAXHEALTH) is 0.23.What is the market cap of Max Healthcare Institute Limited (MAXHEALTH) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Max Healthcare Institute Limited (MAXHEALTH) is ₹86021.16 Cr as of 9th October 2026.What is the 52 week high and low of Max Healthcare Institute Limited (MAXHEALTH) share?
The 52-week high of Max Healthcare Institute Limited (MAXHEALTH) is ₹1221.90 and the 52-week low is ₹870.What is the PE and PB ratio of Max Healthcare Institute Limited (MAXHEALTH) stock?
The P/E (price-to-earnings) ratio of Max Healthcare Institute Limited (MAXHEALTH) is 59.64. The P/B (price-to-book) ratio is 8.00.Which sector does Max Healthcare Institute Limited (MAXHEALTH) belong to?
Max Healthcare Institute Limited (MAXHEALTH) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Max Healthcare Institute Limited (MAXHEALTH) shares?
You can directly buy Max Healthcare Institute Limited (MAXHEALTH) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Max Healthcare Institute Limited
MAXHEALTH Share Price
NSEMAXHEALTH Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
MAXHEALTH Performance & Key Metrics
MAXHEALTH Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 59.02 | 8.00 | 0.23% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 44.80 | 5.62 | 0.51% |
from 24 analysts
Price Upside
Earnings Growth
Rev. Growth
MAXHEALTH Company Profile
Max Healthcare is provider of home health care services including Patient Care, Healthcare Services, and Hospitals.
MAXHEALTH Sentiment Analysis
MAXHEALTH Sentiment Analysis
MAXHEALTH Stock Summary · August 2026
Management described a quarter of strong top-line growth, steady operating performance and an active multi-year expansion plan, while also acknowledging near-term margin and cash flow pressure from new investments and collections delays. Revenue rose 16% year on year to INR 2,982 crore and operating EBITDA increased 15%, with occupancy still above 75% even after a 13% increase in bed capacity and EBITDA margin holding at 24.8%. Management emphasised brownfield-led growth, noting that new beds at Max Smart and Nanavati are ramping, while additional projects at Vaishali, Nanavati and Pune are moving toward commissioning by FY30. They also highlighted Kalinga’s turnaround potential, a more disciplined reduction in unprofitable institutional business, and modest pricing support from insurance renewals. At the same time, free cash flow conversion fell to about 56% as receivables climbed and leverage rose modestly, though still below 1x net debt-to-EBITDA. Near term, management expects oncology pressure to normalize from Q3 FY26 and be fully normalized by Q4, with profitability improving as newly added capacity fills.
MAXHEALTH Stock Growth Drivers
MAXHEALTH Stock Growth Drivers
9Network Growth and Operating Momentum
The company delivered strong core operating performance, with revenue up 16% year on year and
Capacity Expansion and Project Execution
The company is executing a multi-year bed expansion pipeline with visible progress across several projects.
MAXHEALTH Stock Challenges
MAXHEALTH Stock Challenges
7Temporary Margin Compression From Expansion And Acquisition Costs
Operating profitability has weakened sequentially as newly commissioned brownfield capacity and the Kalinga Hospital acquisition
Attrition Risk From Slower Career Progression
Management highlighted that growth is needed to create advancement opportunities for clinicians and management, implying
MAXHEALTH Forecast
MAXHEALTH Forecasts
Price
Revenue
Earnings
MAXHEALTH Share Price Forecast
MAXHEALTH Share Price Forecast
All values in ₹
All values in ₹
MAXHEALTH Company Revenue Forecast
MAXHEALTH Company Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
MAXHEALTH Stock EPS (Earnings Per Share) Forecast
MAXHEALTH Stock EPS (Earnings Per Share) Forecast
All values in ₹
All values in ₹
MAXHEALTH
MAXHEALTH
Income
Balance Sheet
Cash Flow
MAXHEALTH Income Statement
MAXHEALTH Income Statement
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,468.15 | 1,577.63 | 1,748.30 | 1,901.61 | 1,956.66 | 2,064.08 | 2,168.37 | 2,112.90 | 2,190.72 | 2,406.69 | ||||||||||
| Operating & Other expenses | 1,041.37 | 1,155.54 | 1,256.92 | 1,442.81 | 1,398.12 | 1,504.66 | 1,560.32 | 1,577.42 | 1,536.46 | 1,767.72 | ||||||||||
| EBITDA | 426.78 | 422.09 | 491.38 | 458.80 | 558.54 | 559.42 | 608.05 | 535.48 | 654.26 | 638.97 | ||||||||||
| Depreciation/Amortization | 70.32 | 76.90 | 84.15 | 97.54 | 100.83 | 104.14 | 108.10 | 111.27 | 123.02 | 131.66 | ||||||||||
| PBIT | 356.46 | 345.19 | 407.23 | 361.26 | 457.71 | 455.28 | 499.95 | 424.21 | 531.24 | 507.31 | ||||||||||
| Interest & Other Items | 20.73 | 23.88 | 33.54 | 52.39 | 55.21 | 54.85 | 53.92 | 59.67 | 66.66 | 71.00 | ||||||||||
| PBT | 335.73 | 321.31 | 373.69 | 308.87 | 402.50 | 400.43 | 446.03 | 364.54 | 464.58 | 436.31 | ||||||||||
| Taxes & Other Items | 84.19 | 85.04 | 91.88 | 70.07 | 83.50 | 92.46 | -45.27 | 63.62 | 122.36 | 113.35 | ||||||||||
| Net Income | 251.54 | 236.27 | 281.81 | 238.80 | 319.00 | 307.97 | 491.30 | 300.92 | 342.22 | 322.96 | ||||||||||
| EPS | 2.59 | 2.43 | 2.90 | 2.46 | 3.28 | 3.17 | 5.05 | 3.10 | 3.52 | 3.32 |
MAXHEALTH Company Updates
Investor Presentation
MAXHEALTH Stock Peers
MAXHEALTH Past Performance & Peer Comparison
MAXHEALTH Past Performance & Peer Comparison
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Max Healthcare Institute Limited | 59.64 | 8.00 | 0.23% |
| Apollo Hospitals Enterprise Limited | 59.44 | 11.57 | 0.25% |
| Manipal Health Enterprises Limited | 103.38 | 10.48 | — |
| Aster DM Quality Care Limited | 157.17 | 12.62 | 0.25% |
MAXHEALTH Stock Price Comparison
Compare MAXHEALTH with any stock or ETFMAXHEALTH Holdings
MAXHEALTH Shareholdings
MAXHEALTH Promoter Holdings Trend
MAXHEALTH Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
MAXHEALTH Institutional Holdings Trend
MAXHEALTH Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has decreased by 3.61%
MAXHEALTH Shareholding Pattern
MAXHEALTH Shareholding Pattern
MAXHEALTH Shareholding History
MAXHEALTH Shareholding History
Mutual Funds Invested in MAXHEALTH
Mutual Funds Invested in MAXHEALTH
No mutual funds holding trends are available
Top 5 Mutual Funds holding Max Healthcare Institute Limited
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 1.8469% | Percentage of the fund’s portfolio invested in the stock 1.46% | Change in the portfolio weight of the stock over the last 3 months -0.10% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 17/89 (+1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.1907% | Percentage of the fund’s portfolio invested in the stock 6.50% | Change in the portfolio weight of the stock over the last 3 months 2.20% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 2/47 (+5) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.9405% | Percentage of the fund’s portfolio invested in the stock 6.64% | Change in the portfolio weight of the stock over the last 3 months -1.11% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 4/46 (-3) |
Compare 3-month MF holding change on Screener
smallcases containing MAXHEALTH stock
smallcases containing MAXHEALTH stock
Looks like this stock is not in any smallcase yet.
MAXHEALTH Events
MAXHEALTH Events
MAXHEALTH Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
MAXHEALTH Dividend Trend
No dividend trend available
MAXHEALTH Upcoming Dividends
MAXHEALTH Upcoming Dividends
No upcoming dividends are available
MAXHEALTH Past Dividends
MAXHEALTH Past Dividends
Cash Dividend
Ex DateEx DateJul 3, 2026
Dividend/Share
₹2.00
Ex DateEx Date
Jul 3, 2026
Cash Dividend
Ex DateEx DateJul 4, 2025
Dividend/Share
₹1.50
Ex DateEx Date
Jul 4, 2025
Cash Dividend
Ex DateEx DateAug 23, 2024
Dividend/Share
₹1.50
Ex DateEx Date
Aug 23, 2024
Cash Dividend
Ex DateEx DateSep 8, 2023
Dividend/Share
₹1.00
Ex DateEx Date
Sep 8, 2023
MAXHEALTH Stock News & Opinions
MAXHEALTH Stock News & Opinions
Max Healthcare Institute Ltd announced that CARE Ratings Limited has upgraded the credit rating for Crosslay Remedies Limited, a wholly-owned material subsidiary of the company, following enhancements to several facilities. Specifically, the Long Term Bank Facilities amounting to Rs 50.00 (enhanced from Rs 40.00) now carry a CARE AA+; Stable rating, with ST facilities reclassified to LT and a Stable outlook assigned; the Long Term Bank Facilities amounting to Rs 1,211.80 (enhanced from Rs 1,000.00) have been rated CARE AA+; Stable, revised from CARE AA+ (CE); Stable; and the Long Term / Short Term Bank Facilities amounting to Rs 105.00 (enhanced from Rs 40.00) now hold a CARE AA+; Stable LT rating, upgraded from CARE AA-; Stable outlook, with the ST rating reaffirmed and removed from Rating Watch with Positive Implications.
Max Healthcare Institute Ltd announced that CARE Ratings Limited has reaffirmed the credit rating of the company, specifically CARE AA+; Stable for Long Term Bank Facilities amounting to Rs 1,818.88 (enhanced from Rs 1,296.02) and CARE A1+ for Short Term Bank Facilities amounting to Rs 80.00, with the communication received on October 8, 2026, at 2.26 pm (IST), and this disclosure will be hosted on the company’s website at www.maxhealthcare.in.
Apollo Hospitals Enterprise Ltd, Fortis Healthcare Ltd, Yatharth Hospital & Trauma Care Services Ltd and Graphite India Ltd are among the other losers in the BSE's 'A' group today, 30 September 2026.Max Healthcare Institute Ltd lost 7.16% to Rs 913.5 at 14:48 IST.The stock was the biggest loser in the BSE's 'A' group.On the BSE, 5.99 lakh shares were traded on the counter so far as against the average daily volumes of 2.54 lakh shares in the past one month.Apollo Hospitals Enterprise Ltd tumbled 7.13% to Rs 8081.35. The stock was the second biggest loser in 'A' group.On the BSE, 2.84 lakh shares were traded on the counter so far as against the average daily volumes of 21014 shares in the past one month.Fortis Healthcare Ltd crashed 7.13% to Rs 760.6. The stock was the third biggest loser in 'A' group.On the BSE, 2.6 lakh shares were traded on the counter so far as against the average daily volumes of 1.47 lakh shares in the past one month.Yatharth Hospital & Trauma Care Services Ltd pared 6.17% to Rs 1037.45. The stock was the fourth biggest loser in 'A' group.On the BSE, 33058 shares were traded on the counter so far as against the average daily volumes of 53202 shares in the past one month.Graphite India Ltd corrected 5.50% to Rs 759.4. The stock was the fifth biggest loser in 'A' group.On the BSE, 1.51 lakh shares were traded on the counter so far as against the average daily volumes of 2.46 lakh shares in the past one month.
Max Healthcare Institute Limited will close the trading window for securities from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half year ending September 30, 2026, in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company’s code of conduct.
Max Healthcare Institute Limited announced it received confirmation from Kalinga Hospital Ltd., a subsidiary, of the allotment of 50,21,212 equity shares on a rights basis, representing an infusion of Rs 87.87 crore, increasing Max Healthcare’s shareholding in Kalinga Hospital Ltd. from approximately 58.28% to approximately 66.15%.
Max Healthcare Institute Limited announced that its Nomination & Remuneration Committee approved the allotment of 33,765 equity shares with a face value of Rs 10 each to eligible employees under the Max Healthcare Institute Limited - Employee Stock Option Scheme 2022. The allotment, which occurred on September 4, 2026, increased the company’s paid-up equity share capital to Rs 973,31,02,510 and total issued share capital to 97,33,10,251 equity shares.
Max Healthcare Institute Limited announced that its Renewable Energy and Subsidiary Investment Committee approved an additional investment of Rs 87.87 crore by way of subscription to equity shares on a rights basis in Kalinga Hospital Ltd., a subsidiary, to support capital expenditure, modernization, and general corporate requirements, with the transaction expected to be completed within the next 15 days.
Max Healthcare Institute Ltd share price softened by 3.08% to Rs 1008.0 after the company's net profit slipped by 5.63% to Rs 322.96 crore, while revenue from operations gained 10.42% to Rs 2366.17 crore in Q2FY26 over Q1FY26. The market capitalization of Hospital industry group stocks on BSE stood at Rs 5.19 lakh crore, gaining 7.53%. It has eased by 2% over last one week and soared by 26.76% in last one month while the market capitalization of Max Healthcare Institute Ltd has slipped by 6.23% and 4% in the same period respectively. Profit before tax (PBT) of Max Healthcare Institute Ltd stood at Rs 436.31 crore in Q2 FY26, rising 8.96% year-on-year, and declining 6.09% quarter-on-quarter. EBITDA came in at Rs 558 crore, advancing by 14.71% YoY and slipping 0.12% sequentially. Total expenses rose by 14.46% to Rs 1899.38 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 521.16 crore, surging by 20.27% YoY, while employee benefits expense was at Rs 388.18 crore, witnessing a strong rise of 14.08% YoY. For the TTM ended FY26, revenue from operations rose 19.14% to Rs 8373.45 crore, while net profit jumped 34.07% to Rs 1442.41 crore, compared to previous TTM. EBITDA soared by 177927% to Rs 2080.21 crore, and PBT registered a growth of 19.14% to Rs 1675.58 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 1633.32 crore in FY26, as against Rs 1459.31 crore in FY25. Max Healthcare Institute Ltd tumbled by 20.13% in last one year, underperforming the benchmark BSE Sensex which has softened by 2.83% during the same period.
Max Healthcare Institute Limited announced that its Nomination & Remuneration Committee approved the allotment of 3,048 equity shares with a face value of Rs 10 each to eligible employees following the exercise of vested stock options under the Max Healthcare Institute Limited - Employee Stock Option Scheme 2022. Consequently, the company's paid-up equity share capital increased to Rs 973,27,64,860 from Rs 973,27,34,380, with the total number of equity shares outstanding rising to 97,32,76,486.
Max Healthcare Institute Limited will hold a board meeting on Thursday, August 13, 2026, to consider and approve unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, according to a regulatory filing. The trading window for securities of the company will remain closed for designated persons and their immediate relatives until 48 hours after the financial results are declared.
Over the last 5 years, revenue has grown at a yearly rate of 26.65%, vs industry avg of 17.91%
Over the last 5 years, market share increased from 5.95% to 8.31%